Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Recruitment Status: Withdrawn"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Medical+Condition%3A+Covid19%22&type=Subject&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Withdrawn%22
/vufind/Search/Results?lookfor=%22Medical+Condition%3A+Covid19%22&type=Subject&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Withdrawn%22
Search /vufind/Search2/Results?lookfor=%22Medical+Condition%3A+Covid19%22&type=Subject&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Withdrawn%22
PubPharm (179)
1
International ALLIANCE Study of Therapies to prevent progression of COVID-19, a randomized trial - Stage 2 : Therapies to prevent progression of COVID-19, including Quercetin, Zinc, high dose Vitamin D with or without Intravenous Vitamin C, a multi-centre, international, randomized trial: The International ALLIANCE Study - Stage 2
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
International ALLIANCE Study of Therapies to prevent progression of COVID-19, a randomized trial - Stage 2 : Therapies to prevent progression of COVID-19, including Quercetin, Zinc, high dose Vitamin D with or without Intravenous Vitamin C, a multi-centre, international, randomized trial: The International ALLIANCE Study - Stage 2
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
A Study of JT001 Tablets in Caucasian Healthy Subjects after Oral Administrations : An Open-label, Dose-Escalation, Multiple-Dose Phase 1 Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of JT001 Tablets in Caucasian Healthy Subjects after Oral Administrations
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
4
A Study of JT001 Tablets in Caucasian Healthy Subjects after Oral Administrations : An Open-label, Dose-Escalation, Multiple-Dose Phase 1 Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of JT001 Tablets in Caucasian Healthy Subjects after Oral Administrations
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
5
Phase II Safety Single-arm Study of CDK4/6 Inhibition With Palbociclib in Hospitalized, Moderate COVID-19 Cases to Prevent Thromboinflammation : Phase II Safety Single-arm Study of CDK4/6 Inhibition With Palbociclib in Hospitalized, Moderate COVID-19 Cases to Prevent Thromboinflammation
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
6
Nasal Epithelial Genetic and Single Cell RNA COVID-19 Study : Nasal CIliated EPithelial Genetic And Single Cell RNA prOfiLes of miLd, Severe and Very Severe COVID-Nineteen patIents (CIPOLLINI) Study
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
7
Efficacy and Safety of Nitazoxanide for Post Exposure Prophylaxis of COVID-19 : Prospective, Randomized, Double-blind, Parallel, Placebo Controlled Study to Evaluate the Safety and Efficacy of Nitazoxanide 600 mg Three Times a Day for Post Exposure Prophylaxis of COVID-19 in Subjects From Vulnerable Communities
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
8
Efficacy and Safety of Nitazoxanide 600 mg to Treat Mild Ambulatory COVID-19 Patients : Prospective, Randomized, Double-blind, Parallel, Placebo Controlled Study to Evaluate the Safety and Efficacy of Nitazoxanide 600 mg to Treat Ambulatory Adult Subjects Diagnosed With COVID-19 With Mild Symptoms Assisted in the Public Health System of the City of Mesquita
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
9
Immune Response of Asymptomatic EHPAD Employees Infected With COVID-19 : Kinetic of Humoral Immune Response of Asymptomatic Nursing Homes (EHPAD) Employees Infected With Severe Acute Respiratory Syndrome Coronavirus : a Case Control Study
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
10
In-patient COVID-19 Study of Intranasal Foralumab : A Phase 2 Proof-of-concept Study to Evaluate the Safety, Tolerability, and Efficacy of Intranasal Foralumab in Hospitalized Subjects With Severe COVID-19 and Pulmonary Inflammation
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[18]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Recruitment Status: Withdrawn
Medienart
179
Aufsätze
179
E-Artikel
179
E-Ressourcen
Zeitschriftentitel
159
ClinicalTrials.gov
20
WHO International Clinical Trials Registry Plat...
Thema
179
610
Recruitment Status: Withdrawn
157
Study Type: Interventional
70
COVID-19
50
Medical Condition: COVID-19
44
Phase: Phase 2
31
Medical Condition: Covid19
28
Phase: Phase 3
21
Study Type: Observational
17
Pneumonia
15
Phase: Phase 1
11
Infection
11
Phase: Phase 1, Phase 2
10
Medical Condition: Covid-19
8
Medical Condition: COVID-19; COVID-19;Infection...
7
Phase: Phase 4
6
Communicable Diseases
6
Coronavirus Infections
6
Medical Condition: COVID19
6
Severe Acute Respiratory Syndrome
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2
2023
60
2022
69
2021
48
2020
Erscheinungsjahr(e)
Von:
Bis:
Sprache
179
Englisch
Haven't found what you're looking for?
Wird geladen...